[1] Dagdeviren H,Cengiz H,Heydarova U,et al.Intramuscular versus intravenous prophylactic oxytocin for postpartum hemorrhage after vaginal delivery:a randomized controlled study[J].Arch Gynecol Obstet,2016,294(5):911-916. [2] Quibel T.Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage:A Randomized Controlled Trial[J].Obstet Gynecol,2016,128(4):805-811. [3] Elbohoty AE,Mohammed WE,Sweed M,et al.Randomized controlled trial comparing carbetocin,misoprostol,and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery[J].Int J Gynaecol Obstet,2016,134(3):324-328. [4] 兰杰军,钟秀萍,王芳艳,等.卡孕栓与催产素联合或单独使用预防产后出血的临床研究[J].实用药物与临床,2014,17(1):106-108. [5] 李艳丽.卡孕栓与催产素联合用于预防剖宫产产后出血的临床分析[J].中国妇幼保健,2013,28(10):1679-1680. [6] 刘兴会,陈锰.产后出血的药物和手术治疗评价[J].中华妇幼临床医学杂志(电子版),2013,9(2):140-143. [7] Tan J,Cao Q,He GL,et al.Misoprostol versus ergometrine-oxytocin for preventing postpartum hemorrhage:a systematic review and meta-analysis of randomized controlled trials[J].J Evid Based Med,2016,25(6):90-93. [8] Pichon-Riviere A,Glujovsky D,Garay OU,et al.Correction:oxytocin in uniject disposable auto-disable injection system versus standard use for the prevention of postpartum hemorrhage in latin america and the caribbean:a cost-effectiveness analysis[J].PLoS One,2015,10(7):3344-3345. [9] 罗佛园,林娟,冯丽爱.卡孕栓不同时间给药预防产后出血的效果观察[J].齐齐哈尔医学院学报,2013,34(22):3410-3411. [10] 邱娟.卡孕栓配伍卡前列素氨丁三醇在宫缩乏力性产后出血产妇中的临床价值[J].中国卫生产业,2014,11(23):65-66. [11] 孙利娟,尹利荣.卡孕栓直肠给药联合静脉缩宫素预防产后出血的临床观察[J].齐齐哈尔医学院学报,2016,37(28):3523-3524. [12] 王丹凤,华秋琴,胡小娟.不同途径应用卡孕栓预防产后出血临床效果观察[J].中国妇幼保健,2013,28(11):1844-1845. [13] 许艳华,石艳丽,李伟.卡孕栓联合宫缩素预防产后出血98例效果观察[J].中国医学工程,2015,23(1):133-138.
2018, Vol. 35 
